<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000306489">
  <TermName>myelosclerosis with myeloid metaplasia</TermName>
  <TermPronunciation>(MY-eh-loh-skleh-ROH-sis ... MY-eh-loyd meh-tuh-PLAY-zhuh)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A progressive, chronic disease in which the bone marrow is replaced by fibrous tissue and blood is made in organs such as the liver and the spleen, instead of in the bone marrow. This disease is marked by an enlarged spleen and progressive anemia. Also called agnogenic myeloid metaplasia, chronic idiopathic myelofibrosis, idiopathic myelofibrosis, and primary myelofibrosis.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000710197" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;myelosclerosis with myeloid metaplasia&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000710198" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mieloesclerosis con metaplasia mieloide&quot;" language="es" id="_4"/>
  <SpanishTermName>mieloesclerosis con metaplasia mieloide</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Enfermedad crónica progresiva en la que la médula ósea es reemplazada por tejido fibroso y la sangre se produce en órganos tales como el hígado y el bazo, en vez de la médula ósea. Esta enfermedad se caracteriza por el agrandamiento del bazo y anemia progresiva. También se llama metaplasia mieloide agnógena, mielofibrosis idiopática, mielofibrosis idiopática crónica y mielofibrosis primaria.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-05-23</DateFirstPublished>
  <DateLastModified>2007-04-26</DateLastModified>
</GlossaryTerm>
